Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1

World Journal of Surgery

Volumn 30, Issue 5, 2006, Pages 643-653

  Kouvaraki, Maria A ^a   Shapiro, Suzanne E ^a   Cote, Gilbert J ^a   Lee, Jeffrey E ^a   Yao, James C ^a   Waguespack, Steven G ^a   Gagel, Robert F ^a   Evans, Douglas B ^a   Perrier, Nancy D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; ENUCLEATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646559510     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0360-y     Document Type: Article

References (39)

1. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-5671.
2. Brandi ML, Marx SJ, Aurbach GD, et al. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev 1987;8:391-405.
3. Ki Wong F, Burgess F, Nordenskjold M, et al. Multiple endocrine neoplasia type 1. Semin Cancer Biol 2000;10:299-312.
4. Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 1998;243:465-470.
5. Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 1996;89:653-669.
6. Marx S, Spiegel AM, Skarulis MC, et al. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 1998;129:484-494.
7. Gibril F, Schumann M, Pace A, et al. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 2004;83:43-83.
8. Schussheim DH, Skarulis MC, Agarwal SK, et al. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 2001;12:173-178.
9. Thompson NW. Multiple endocrine neoplasia type 1: surgical therapy. Cancer Treat Res 1997;89:407-419.
10. Carty SE, Helm AK, Amico JA, et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 1998;124:1106-1114.
11. Dean PG, van Heerden JA, Farley DR, et al. Are patients with multiple endocrine neoplasia type 1 prone to premature death? World J Surg 2000;24:1437-1441.
12. Ruszniewski P, Podevin P, Cadiot G, et al. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia. Pancreas 1993;8:295-304.
13. Norton JA, Alexander HR, Fraker DL, et al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 2001;234:495-505.
14. Wilkinson S, Teh BT, Davey KR, et al. Cause of death in multiple endocrine neoplasia type 1. Arch Surg 1993;128:683-690.
15. Thompson NW, Lloyd RV, Nishiyama RH, et al. MEN1 pancreas: a histological and immunohistochemical study. World J Surg 1984;8:561-574.
16. Bartsch DK, Langer P, Wild A, et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 2000;128:958-966.
17. Kouvaraki MA, Lee JE, Shapiro SE, et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 2002;137:641-647.
18. Sato M, Matsubara S, Miyauchi A, et al. Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families. J Med Genet 1998;35:915-919.
19. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:257-481.
20. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
21. Cox D. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
22. Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990;322:723-727.
23. Van Heerden JA, Smith SL, Miller LJ. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. Surgery 1986;100:971-977.
24. Sheppard BC, Norton JA, Doppman JL, et al. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery 1989;106:1108-1117.
25. Thompson NW. Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Oncol Clin N Am 1998;7:881-891.
26. Samaan NA, Ouais S, Ordonez NG, et al. Multiple endocrine syndrome type 1: clinical, laboratory findings, and management in five families. Cancer 1989;64:741-752.
27. Mignon M, Ruszniewski P, Podevin P, et al. Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type 1. World J Surg 1993;17:489-497.
28. Lowney JK, Frisella MM, Lairmore TC, et al. Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery 1998;124:1043-1049.
29. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635-644.
30. Lairmore TC, Chen VY, DeBenedetti MK, et al. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 2000;231:909-918.
31. Levy-Bohbot N, Merle C, Goudet P, et al. Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, vipomas, and somatostatinomas: study from the GTE (Groupe Des Tumeurs Endocrines) registry. Gastroenterol Clin Biol 2004;28:1075-1081.
32. Weber HC, Venzon DJ, Lin JT, et al. Determinants of metastatic rate and survival in patients with Zollinger- Ellison syndrome: a prospective long-term study. Gastroenterology 1995;108:1637-1649.
33. Skogseid B, Eriksson B, Lundqvist G, et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991;73:281-287.
34. Skogseid B, Oberg K, Eriksson B, et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1. World J Surg 1996;20:872-877.
35. Grama D, Skogseid B, Wilander E, et al. Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg 1992;16:611-619.
36. Skogseid B, Oberg K, Akerstrom G, et al. Limited tumor involvement found at multiple endocrine neoplasia type 1 pancreatic exploration: can it be predicted by preoperative tumor localization? World J Surg 1998;22:673-678.
37. Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease: results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 1998;243:495-500.
38. Tonelli F, Fratini G, Falchetti A, et al. Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience. J Intern Med 2005;257:38-49.
39. Clark OH, Ajani J, Benson AB III, et al. Nccn Oncology Practice Guidelines, version 1.2005. National Comprehensive Cancer Network, Jenkin town, PA, 2005.